Group One Trading’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,891
| Closed | -$11K | – | 8277 |
|
|
2022
Q4 | $11K | Sell |
1,891
-579
| -23% | -$3.04K | ﹤0.01% | 5983 |
|
|
2022
Q3 | $17K | Sell |
2,470
-5,730
| -70% | -$34.7K | ﹤0.01% | 6201 |
|
|
2022
Q2 | $35K | Buy |
8,200
+7,000
| +583% | +$27.7K | ﹤0.01% | 5874 |
|
|
2022
Q1 | $4K | Buy |
1,200
+500
| +71% | +$1.58K | ﹤0.01% | 7586 |
|
|
2021
Q4 | $2K | Buy |
700
+100
| +17% | +$333 | ﹤0.01% | 7942 |
|
|
2021
Q3 | $2K | Sell |
600
-2,500
| -81% | -$8.76K | ﹤0.01% | 7987 |
|
|
2021
Q2 | $13K | Buy |
+3,100
| New | +$13.1K | ﹤0.01% | 7423 |
|
|
2021
Q1 | – | Sell |
-89
| Closed | -$719 | – | 8188 |
|
|
2020
Q4 | $1K | Hold |
89
| – | – | ﹤0.01% | 6377 |
|
|
2020
Q3 | $1K | Buy |
+89
| New | +$877 | ﹤0.01% | 5978 |
|
|
2020
Q2 | – | Sell |
-1,126
| Closed | -$10.8K | – | 6347 |
|
|
2020
Q1 | $10K | Sell |
1,126
-8,938
| -89% | -$88.1K | ﹤0.01% | 4581 |
|
|
2019
Q4 | $93K | Sell |
10,064
-14,395
| -59% | -$102K | ﹤0.01% | 3686 |
|
|
2019
Q3 | $144K | Buy |
24,459
+16,086
| +192% | +$171K | ﹤0.01% | 3314 |
|
|
2019
Q2 | $100K | Buy |
8,373
+4,551
| +119% | +$48.9K | ﹤0.01% | 3350 |
|
|
2019
Q1 | $46K | Buy |
3,822
+2,822
| +282% | +$41.6K | ﹤0.01% | 3613 |
|
|
2018
Q4 | $13K | Buy |
1,000
+400
| +67% | +$5.52K | ﹤0.01% | 4188 |
|
|
2018
Q3 | $9K | Sell |
600
-265
| -31% | -$4.17K | ﹤0.01% | 4702 |
|
|
2018
Q2 | $15K | Buy |
+865
| New | +$16.8K | ﹤0.01% | 4492 |
|
|
2017
Q3 | – | Sell |
-28,597
| Closed | -$415K | – | 5296 |
|
|
2017
Q2 | $399K | Buy |
+28,597
| New | +$421K | ﹤0.01% | 2131 |
|
|
2016
Q4 | – | Sell |
-1,007
| Closed | -$10K | – | 4955 |
|
|
2016
Q3 | $10K | Sell |
1,007
-100
| -9% | -$1.09K | ﹤0.01% | 4054 |
|
|
2016
Q2 | $12K | Buy |
1,107
+407
| +58% | +$5.18K | ﹤0.01% | 4022 |
|
|
2016
Q1 | $10K | Sell |
700
-2,100
| -75% | -$30.2K | ﹤0.01% | 4023 |
|
|
2015
Q4 | $53K | Sell |
2,800
-1,100
| -28% | -$23.9K | ﹤0.01% | 3375 |
|
|
2015
Q3 | $73K | Buy |
+3,900
| New | +$66.3K | ﹤0.01% | 3285 |
|
Group One Trading's CNCE Position: Q1 2023 in Review
Group One Trading sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 1,891 shares — an estimated $11K sold.
Group One Trading first reported a position in CNCE in Q3 2015 and held it in 23 quarters. The position peaked at $399K in Q2 2017. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.
- Group One Trading reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Group One Trading sold 1,891 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $11K.
- Group One Trading first reported a position in Concert Pharmaceuticals, Inc. in Q3 2015 and held it in 23 quarters.
- Group One Trading's Concert Pharmaceuticals, Inc. position peaked at $399K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.
Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.